标题
Management of
NAFLD
in primary care settings
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume 42, Issue 11, Pages 2377-2389
出版商
Wiley
发表日期
2022-08-21
DOI
10.1111/liv.15404
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials
- (2022) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
- (2022) Richeek Pradhan et al. DIABETES CARE
- Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
- (2022) Alessandro Mantovani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Nonalcoholic Fatty Liver Disease and Accelerated Loss of Skeletal Muscle Mass: A Longitudinal Cohort Study
- (2022) Dong Hyun Sinn et al. HEPATOLOGY
- Knowledge of liver fibrosis stage among adults with NAFLD / NASH improves adherence to lifestyle changes
- (2022) Patrizia Carrieri et al. LIVER INTERNATIONAL
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort
- (2021) Miguel H. Malespin et al. Clinical Gastroenterology and Hepatology
- Co-Medication and nutrition in HCC: Potentially preventative strategies in Hepatocellular carcinoma (HCC)
- (2021) Alexander Kusnik et al. DIGESTIVE DISEASES
- Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
- (2021) Anat Yaskolka Meir et al. GUT
- A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis
- (2021) Shuen Sung et al. BMC GASTROENTEROLOGY
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
- (2021) Chandani Patel Chavez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ultra‐processed food is associated with features of metabolic syndrome and non‐alcoholic fatty liver disease
- (2021) Dana Ivancovsky‐Wajcman et al. LIVER INTERNATIONAL
- PPAR‐γ‐induced Changes in Visceral Fat and Adiponectin Levels are Associated with Improvement of Steatohepatitis in Patients with NASH
- (2021) Amalia Gastaldelli et al. LIVER INTERNATIONAL
- Dietary carbohydrates and fats in nonalcoholic fatty liver disease
- (2021) Hannele Yki-Järvinen et al. Nature Reviews Gastroenterology & Hepatology
- Defining comprehensive models of care for NAFLD
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Baveno VII – Renewing consensus in portal hypertension
- (2021) Roberto de Franchis et al. JOURNAL OF HEPATOLOGY
- The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
- (2021) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
- (2021) Tom H Karlsen et al. LANCET
- Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
- (2021) V. Ratziu et al. NATURE MEDICINE
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
- (2021) Naoko Nakanishi et al. Scientific Reports
- Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes
- (2020) Kenneth Cusi DIABETES CARE
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study
- (2020) Hye Won Lee et al. HEPATOLOGY
- Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease
- (2020) Donghee Kim et al. HEPATOLOGY
- Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis
- (2020) Keith M. Wirth et al. ANNALS OF SURGERY
- Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis
- (2020) Eduardo Vilar-Gomez et al. Clinical Gastroenterology and Hepatology
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
- (2020) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Benefits and Risks of Bariatric Surgery in Adults
- (2020) David E. Arterburn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gut microbial metabolites as multi-kingdom intermediates
- (2020) Kimberly A. Krautkramer et al. NATURE REVIEWS MICROBIOLOGY
- Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD
- (2020) V. H. Nguyen et al. JOURNAL OF INTERNAL MEDICINE
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESPEN guideline on clinical nutrition in liver disease
- (2019) Mathias Plauth et al. CLINICAL NUTRITION
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis
- (2019) Wah-Kheong Chan et al. Clinical Gastroenterology and Hepatology
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
- (2019) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
- (2019) Bhagirath Chaurasia et al. SCIENCE
- Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
- (2019) Sabine Kahl et al. DIABETES CARE
- Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the Multiethnic Cohort
- (2019) Mazen Noureddin et al. HEPATOLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Guideline Recommendations for Obesity Management
- (2018) Donna H. Ryan et al. MEDICAL CLINICS OF NORTH AMERICA
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses
- (2018) Jaehee Ahn et al. CLINICAL NUTRITION
- Age-Related Decrease in Skeletal Muscle Mass Is An Independent Risk Factor for Incident NAFLD: A 10-Year Retrospective Cohort Study
- (2018) Min Jung Lee et al. Gut and Liver
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
- (2018) Kenneth Cusi et al. DIABETES OBESITY & METABOLISM
- Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis
- (2018) Eduardo Vilar-Gomez et al. HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
- (2017) Shira Zelber-Sagi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- (2017) Olga Vaccaro et al. Lancet Diabetes & Endocrinology
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools
- (2017) Yftach Gepner et al. CIRCULATION
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
- (2015) Wilfrid Mazier et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Hypoxia and Adipocyte Physiology: Implications for Adipose Tissue Dysfunction in Obesity
- (2014) Paul Trayhurn Annual Review of Nutrition
- Pleiotropic Roles of Bile Acids in Metabolism
- (2013) Thomas Q. de Aguiar Vallim et al. Cell Metabolism
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- Four-Year Weight Losses in the Look AHEAD Study: Factors Associated With Long-Term Success
- (2011) Thomas A. Wadden et al. Obesity
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty liver and lipotoxicity
- (2009) Michael Trauner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
- (2008) V. W.-S. WONG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now